tag:blogger.com,1999:blog-9551150.post3484022516505274108..comments2024-03-28T01:27:23.408-04:00Comments on Health Care Renewal: A $1 Million CEO for a $27 Million CorporationRoy M. Poses MDhttp://www.blogger.com/profile/00497209843184497847noreply@blogger.comBlogger4125tag:blogger.com,1999:blog-9551150.post-31608630345371172492009-01-24T22:14:00.000-05:002009-01-24T22:14:00.000-05:00Fantastic article. The entire premise of obscene e...Fantastic article. The entire premise of obscene executive compensation was stock appreciation. Lets not have amnesia here, this was repeated over and over again. "You have to pay for performance." Now that stocks are down, they are no longer measures. So which is it. What is wrong with working for straight salary, everyone else does it.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-4037269090188721612009-01-17T11:39:00.000-05:002009-01-17T11:39:00.000-05:00We seem to be getting more comments like that prov...We seem to be getting more comments like that provided by "anonymous" above. <BR/><BR/>Hiding behind the anonymity we allow should any whistle-blowers or others who challenge the powers that be, this comment defends the powers that be. Furthermore, he or she does so by tossing about red herrings.<BR/><BR/>The post above said nothing about, and surely did not criticize the line employees of CellRoy M. Poses MDhttps://www.blogger.com/profile/00497209843184497847noreply@blogger.comtag:blogger.com,1999:blog-9551150.post-18710961838424317722009-01-16T19:19:00.000-05:002009-01-16T19:19:00.000-05:00First, under the company's incentive program all e...First, under the company's incentive program all employees are eligble to benefit should the company meet milestones set by the Board. Most of the milestones relate to bringing new cancer drugs to patients. Much progress was made in 2008 on these drugs--hence the incentives. CTI is a company that has not asked for government bailout and has avoided layoffs. Of course your blog was based on a Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-64814452518380200722009-01-16T19:10:00.000-05:002009-01-16T19:10:00.000-05:00Company spokesman Dan Eramian, one of the five New...<I>Company spokesman Dan Eramian, one of the five New Year's Eve awardees, says that 'in this market environment, stock prices are not valid measures of company performance.'</I><BR/><BR/>On the company's homepage I find under the "Products" tab exactly one product: Zevalin®, for relapsed or refractory, low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL). <BR/><BR/>Zevalin® was acquiredInformaticsMDhttps://www.blogger.com/profile/03994321680366572701noreply@blogger.com